{"organizations": [], "uuid": "8cc847510bddfbaec21e92f9ba3c52dc1b830b1b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/public/resources/images/BN-KQ004_blind1_G_20151005175552.jpg", "site_section": "http://www.wsj.com/news/business", "section_title": "Business &amp; Finance News - Wall Street Journal", "url": "http://www.wsj.com/articles/gene-therapy-for-visually-impaired-shows-promise-1444082583", "country": "", "title": "Gene Therapy for Visually Impaired Shows Promise", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "Gene Therapy for Visually Impaired Shows Promise - WSJ", "spam_score": 0.0, "site_type": "news", "published": "2015-10-06T02:08:00.000+03:00", "replies_count": 0, "uuid": "8cc847510bddfbaec21e92f9ba3c52dc1b830b1b"}, "author": "Peter Loftus", "url": "http://www.wsj.com/articles/gene-therapy-for-visually-impaired-shows-promise-1444082583", "ord_in_thread": 0, "title": "Gene Therapy for Visually Impaired Shows Promise", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Biotechnology startup Spark Therapeutics Inc. said its experimental gene therapy improved vision among patients with hereditary vision impairment in a clinical trial, without the serious safety problems that have dogged the emerging field of gene therapy in the past.\nThe Philadelphia-based company announced the results in a news release, with few details. Spark says additional data will be presented at a medical meeting in Paris on... ", "external_links": [], "published": "2015-10-06T02:08:00.000+03:00", "crawled": "2015-10-06T01:34:50.066+03:00", "highlightTitle": ""}